Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas.
Saved in:
| Title: | Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas. |
|---|---|
| Authors: | Wilky BA; University of Colorado Cancer Center, Aurora, CO., Schwartz GK; Case Comprehensive Cancer Center, Cleveland, OH., Gordon MS; HonorHealth Research Institute, Scottsdale, AZ., El-Khoueiry AB; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA., Bullock AJ; Beth Israel Deaconess Medical Center, Boston, MA., Henick B; Herbert Irving Comprehensive Cancer Center at Columbia University School of Medicine, New York, NY., Agulnik M; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA., Singh A; University of California Los Angeles, Los Angeles, CA., Mahadevan D; The University of Texas Health Sciences Center at San Antonio, San Antonio, TX., Stebbing J; Anglia Ruskin University, School of Life Sciences, Cambridge, United Kingdom., Delepine C; Agenus Inc, Lexington, MA., Chand D; Agenus Inc, Lexington, MA., Avagyan M; Agenus Inc, Lexington, MA., Wu W; Agenus Inc, Lexington, MA., Johnson B; Agenus Inc, Lexington, MA., Grossman JE; Agenus Inc, Lexington, MA., O'Day S; Agenus Inc, Lexington, MA., Trent JC; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Jones RL; The Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom., Tsimberidou AM; The University of Texas MD Anderson Cancer Center, Houston, TX. |
| Source: | Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2025 Apr 10; Vol. 43 (11), pp. 1358-1368. Date of Electronic Publication: 2025 Jan 27. |
| Publication Type: | Journal Article; Clinical Trial, Phase I; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
